NCI Alliance for Nanotechnology in Cancer – from academic research to clinical interventions

Relative Citation Ratio (RCR): A New Metric That Uses Citation Rates to Measure Influence at the Article Level

(2016) B. Ian Hutchins et al.   PLOS BIOLOGY

Future Opportunities in Cancer Nanotechnology--NCI Strategic Workshop Report

(2014) P. Grodzinski et al.   CANCER RESEARCH

NCI investment in nanotechnology: achievements and challenges for the future

(2014) Anthony Dickherber et al.   Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology

Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology

(2013) U. Prabhakar et al.   CANCER RESEARCH

Best Practices in Cancer Nanotechnology: Perspective from NCI Nanotechnology Alliance

(2012) W. C. Zamboni et al.   CLINICAL CANCER RESEARCH

Company Profile: Kindling translational cancer nanotechnology research

(2012) Sandra Chapman et al.   Nanomedicine

Recent Advances from the National Cancer Institute Alliance for Nanotechnology in Cancer

(2010) Dorothy Farrell et al.   ACS Nano

Strategic Workshops on Cancer Nanotechnology

(2010) Larry A. Nagahara et al.   CANCER RESEARCH

Nanotechnology-Based Cancer Therapeutics—Promise and Challenge—Lessons Learned Through the NCI Alliance for Nanotechnology in Cancer

(2010) Dorothy Farrell et al.   PHARMACEUTICAL RESEARCH